Top Markets
Coin of the day
Human Metabolome Technologies, Inc. Human Metabolome Technologies, Inc.

Human Metabolome Technologies, Inc.

6090
Classificação em ações #29370
Human Metabolome Technologies, Inc. is a biotechnology company based in... Human Metabolome Technologies, Inc. is a biotechnology company based in Tsuruoka, Japan, established in 2003. It focuses on developing and providing metabolomics technologies and solutions for a range of applications, including drug discovery, disease diagnosis, and food production primarily within Japan. The company offers a comprehensive suite of metabolome analysis services, encompassing global profiling, targeted assays, flux analysis, and lipidomics. Additionally, it develops biomarkers, such as Phosphorylethanolamine, which is measured in blood plasma as a marker for major depressive disorder. HMT's solutions address diverse areas like cancer metabolism, infectious diseases, basic and clinical research, food and nutrition, and microbiome studies. The company also fosters collaborations, notably with the Institute for Advanced Biosciences and Keio University, to further advance metabolome analysis technology.
Preço da ação
$3.86
Valor de mercado
$21.49M
Variação (1 dia)
-0.17%
Variação (1 ano)
-25.27%
País
JP
Negociar Human Metabolome Technologies, Inc. (6090)

Categoria

Histórico de preços das ações de Human Metabolome Technologies, Inc. (6090)
Preço de fecho mais alto: $3.90 em 2026-08-01

Preço de fecho mais baixo: $38.92 em 2013-12-01
Histórico de preços das ações da Human Metabolome Technologies, Inc. de 2013 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) 6.42%
2025 5.53%
2024 -8.60%
2023 -16.34%
2022 -3.84%
2021 -27.40%
2020 -0.20%
2019 -31.00%
2018 -39.33%
2017 33.64%
2016 94.29%
2015 -35.63%
2014 -72.82%
2013 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$543.58 39.11%
US
$1.02K 55.96%
NL
$149.47 435.54%
US
$117.42 -19.34%
AU
$755.62 8.92%
CH